| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,394 |
9,288 |
$647K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,470 |
4,339 |
$388K |
| 92587 |
|
3,180 |
3,170 |
$80K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
821 |
821 |
$77K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
910 |
910 |
$74K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
824 |
824 |
$72K |
| 94010 |
|
2,771 |
2,770 |
$66K |
| 99401 |
|
2,930 |
2,858 |
$47K |
| 93000 |
|
3,079 |
3,070 |
$44K |
| 94060 |
|
997 |
959 |
$40K |
| 87428 |
|
622 |
600 |
$18K |
| 81002 |
|
5,634 |
5,483 |
$9K |
| 90686 |
|
489 |
489 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
94 |
94 |
$8K |
| 96127 |
|
2,780 |
2,780 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
492 |
488 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
332 |
296 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
530 |
505 |
$4K |
| 99385 |
|
36 |
36 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
117 |
107 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
168 |
167 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
7,325 |
7,174 |
$1K |
| 99384 |
|
14 |
14 |
$1K |
| 82962 |
|
1,381 |
1,373 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
218 |
212 |
$1K |
| 90656 |
|
49 |
49 |
$800.71 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
64 |
31 |
$723.08 |
| A4617 |
Mouth piece |
3,208 |
3,152 |
$427.95 |
| 90756 |
|
15 |
15 |
$370.25 |
| 99173 |
|
236 |
236 |
$340.40 |
| 1159F |
|
974 |
972 |
$90.00 |
| 1160F |
|
975 |
973 |
$90.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
923 |
887 |
$34.68 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
53 |
51 |
$23.10 |
| 36416 |
|
492 |
488 |
$14.92 |
| 99072 |
|
29 |
25 |
$8.00 |
| 3008F |
|
3,062 |
2,777 |
$0.00 |
| 3011F |
|
50 |
50 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
330 |
303 |
$0.00 |
| 0513F |
|
84 |
80 |
$0.00 |
| 94760 |
|
64 |
53 |
$0.00 |
| 99429 |
|
12 |
12 |
$0.00 |
| 4037F |
|
14 |
14 |
$0.00 |
| 3725F |
|
1,353 |
1,353 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,263 |
1,127 |
$0.00 |